37 results about "Rosacea flaccida" patented technology

Disclosed are compositions and their use for the treatment of human skin, particularly facial skin, to alleviate the symptoms of cosmetic or dermatologic skin conditions. The compositions include black willow bark extract, cat's claw extract, and dragon's blood extract. The compositions ameliorate skin conditions including acne, rosacea, blemish, dermatitis, eczema, or the like.

The invention relates to a medicament for treating face acne, and particularly relates to a 'Miancuojing ointment' for treating acne diseases such as comedo, seborrheic dermatitis, rosacea, and the like. The medicament is prepared from metronidazole, chloramphenicol, borneol, sublimed sulfur, stearic acid, glycerin monostearate, lecithin, propylene glycol, triethanolamine, tween, distilled water and the like through process steps; the medicament of the invention has the effects of resisting propionibacterium acnes, dissolving skin cutin, and reducing skin free lipid, and has significant curative effects on acne (comedo), seborrheic dermatitis, and rosacea.

The invention relates to a pharmaceutical composition consisting of snail slime Helix aspersa muller (Cryptomphalus aspersus) (20% to 50%), camomile extract (1-4%), propolis 1l-4%), and pharmaceutically acceptable excipients and / or additives for forming a formulation of low, intermediate or high viscosity (10 to 1000 Pa-s). Said composition is in the form of a lotion, soap, cream or gel, which is embedded in a gauze-type fabric in the form of a plaster that can be applied to lesions caused by the different types of rosacea. The composition can also contain natural extracts such as marigold extract, honey and vegetable oils. The invention also relates to the method for producing the composition and to the use thereof for preparing a medicament or device for preventing, treating or curing lesions caused by rosacea, on the skin of the face or the body.

The present invention relates generally to methods of use and compositions useful for treating skin. The composition includes a combination of Phoenix dactylifera extract, tea tree oil, Myrothamnus flabellifolia extract, and saccharide isomerate. This combination can be used to create topical skin compositions that reduce rosacea, erythema, and / or inflammation, and inhibit nitric oxide synthase, increase α2A adrenergic receptor agonist activity, reduce oxidation, increase anti-oxidant capacity of a composition or of skin, inhibit cyclooxygenase-2 (COX-2) production, inhibit vascular endothelial growth factor (VEGF) production, inhibit interleukin-6 (IL-6) and interleukin-8 (IL-8) production, reduce tumor necrosis factor alpha (TNF-α) production, increase collagen stimulation, increase lysyl oxidase expression, inhibit matrix metalloproteinase 1 (MMP1) activity, increase occludin production, increase filaggrin production, and increase skin moisturization. This combination can also be used to reduce transient or persistent erythema, telangiectasia, inflammatory papules and / or pustules, transient or persistent flushing of the skin, and / or hyperplasia of a connective tissue.

The invention discloses an extracting method of folium artemisiae argyi mite-removing cream and folium artemisiae argyi volatile oil. Raw materials comprise folium artemisiae argyi volatile oil, jojoba oil, soya bean lecithin, vitamin E acetate, glycerol, polyacrylamide and deionized water. Compared with prior art, the folium artemisiae argyi mite-removing cream provided in the invention is prepared by a thermal preparing method, the mite-removing cream contains the folium artemisiae argyi volatile oil which is prepared by using supercritical CO2 extraction and rotary evaporation methods, and the mite-removing cream has an action of inhibiting bacteria and killing mites, and retains the original fragrance of folium artemisiae argyi without any essence addition; besides, the product does not irritate skin, fast permeates and gives dry, non-greasy, smooth moistening feelings to the skin, can be used for treating a series of facial diseases such as acnes, rosacea, epifolliculitis and blepharitis ciliaris caused by facial vermiform mites.

The invention discloses a medicament for repairing skin and a preparation method thereof. The medicament comprises the following raw materials in part by weight: 0.9 to 150 parts of ginseng, 5 to 295 parts of bletilla, 20 to 300 parts of tree poney, 10 to 250 parts of Chinese angelica, 15 to 120 parts of cassia bark, 0.8 to 150 parts of glossy ganoderma and 0.5 to 150 parts of pollen. The preparation method comprises the following steps of: putting the raw materials into a container; adding water to flood the raw materials; decocting for 30 to 80 minutes hermetically or evaporating and decocting for 60 to 120 minutes; taking decoction out; adding the water to flood the raw materials; decocting hermetically or evaporating and decocting for the second time and the third time; mixing the decoction at three times; and packaging to form the medicament. The medicament achieves the effect of treating diseases such as skin allergy pruritus, blain scars, chloasma, butterfly rash, cyasma, senile plaque, sunburn, genetic freckles, fat granules, imbalance in sebum secretion, blackhead trichopore and the like which are caused by acnes, tinea corporis, acne rosacea, blood streak, hormone and the like safely and quickly under the synergistic action of the Chinese medicinal herbs.

A treatment for ocular rosacea using p38 and Erk kinase pathway inhibitors, which are believed to block the initial reaction to rosacea triggers and thus make it possible to prevent or minimize the skin reaction. The treatment is premised on a careful analysis of the alteration of cell-signaling pathways that facilitate the development of rosacea, which led to the identification of discrete targets for highly specific therapeutic intervention in the management of rosacea.

A composition for use in the treatment of rosacea includes a multi-kinase inhibitor that inhibits both a Vascular Endothelial Growth Factor Receptor and a Fibroblast Growth Factor Receptor. A method for treating rosacea for a patient includes inhibiting a Vascular Endothelial Growth Factor Receptor of the patient; and inhibiting a Fibroblast Growth Factor Receptor of the patient.

The invention relates to a traditional Chinese medicine preparation which is used for treating rosacea. The medicine is made from the materials according to the following weight account: 13 to15g for figwort root and rhubarb root each, 10 to 12g for garden burnet root, red peony root, raw cattail pollen, monkshoodvine root-bark and tongue herb of adder each and 7 to 8g for fineleaf schizonepeta herb. The invention is characterized by novel prescription, low cost, convenient preparation and remarkable effects.